Fig. 1From: Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trialsImputation of week-54 CT-P13 3.5 results based on CT-P13 regression model. EU, European Union; IV, intravenous; MTX, methotrexate; PD, pharmacodynamics; PK, pharmacokineticsBack to article page